Difference between revisions of "Template:Team:TU Eindhoven/Stakeholders HTML"

Line 14: Line 14:
 
<ul>
 
<ul>
  
−
<li><span class="tekst1I">RIVM & Rathenau</span><img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
+
<li><span class="tekst1I">RIVM & Rathenau</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 
<div class="spoiler" id="spoiler2">
 
<div class="spoiler" id="spoiler2">
 
<div class="textImage">
 
<div class="textImage">
Line 29: Line 29:
 
<div class="linkTxt">
 
<div class="linkTxt">
 
<span class="caption">
 
<span class="caption">
−
We our project to policymakers attending the SynBio convention and held a discussion afterwards.
+
We presented our project to policymakers attending the SynBio convention and held a discussion afterwards.
 
</span>
 
</span>
 
</div>
 
</div>
Line 37: Line 37:
 
</li>
 
</li>
  
 +
<li><span class="tekst1I">Bureau GGO</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
//text goes here
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//image caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
 +
 +
<li><span class="tekst1I">Virgil Rerimassie</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
//text goes here
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
 +
 +
<li><span class="tekst1I">RIVM Regelgeving</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
//text goes here
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
 +
</ul>
 +
<br />
 +
<br />
 +
<h2>Intellectual Property Rights</h2><br />
 +
A possible obstacle for our design is the fact that we make use of aptamers as one of the main components; many of the discovered aptamers are currently still patented. Therefore, it was interesting to explore if this could pose any further problems in the future. Therefore, we contacted some experts on the area of patent law. An overview is given below:
 +
<ul>
 +
 +
<li><span class="tekst1I">Ir. P.H. (Peter) van Dongen - RVO/Agentschap NL - Patent advisor for universities and technological institutes</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
Ir. Van Dongen is very experienced when it comes to patent law. He explained to us some of the basic principles behind it and some factors we should pay attention to.
 +
<br />
 +
Patents are granted to any scientist who applied for it and who came up with a novel invention that was never earlier described anywhere in the world, that is not obvious and that could be exploited economically. Hereby it is important to consider that patents are granted per country and it might not be economically favourable for some companies to apply for a patent in small countries like the Netherlands. Patent keepers need to pay tax  for the patent they hold in each country, so sometimes it is not beneficious to have a patent-right in each country.
 +
<br />
 +
Once a company/institute has patent on a specific invention, it has rights to exploit this product economically for 20 years. People can buy the patent or ask for a license, in which case part of the profit is directly transferred to the company who owns the patent.
 +
<br />
 +
Ir. Van Dongen doesn’t foresee much problems in our research. He could tell us that there is an exception to the patent law when it comes to the use of a product for scientific research. Only if we were to introduce our device to the market we would encounter patent regulation.
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
 +
 +
<li><span class="tekst1I">Ir. Annika van Rosmalen - Responsible at HollandBio for communication about bio-based technologies</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
We talked to Ir. Van Rosmalen about the potential of our device. Since Ir. Van Rosmalen works at HollandBio, a Dutch association for companies involved in the production of bio-based technologies, we figured she would have some insights into regulation involved in bio-based technologies like ours.
 +
<br />
 +
Ir. Van Rosmalen was quite enthusiastic about the idea of an quick and easy detection-device. She advised us to further emphasize the advantages of using bacteria in order to avoid a lot of ethical complaints.
 +
<br />
 +
About patent-regulation she could tell us that the 20 years of patent rights usually only give the patent-holder only 15 years to earn back his/her expenses. This is because an application for patents on different aspects of the design is made at the beginning of the research. However usually it takes at least 5 more years for the research to be published.
 +
<br />
 +
One other important aspect is that the patent-holders themselves are responsible to keep check of any illegal use of their product. This is not supported by any other agency. Therefore it takes quite some work to keep your patented product safe.
 +
 +
<li><span class="tekst1I">Patentpunt</span> <img src="https://static.igem.org/mediawiki/2015/8/87/TU_Eindhoven_Ingeklapt.png" id="spoilerbutton2" class="spoilerbutton">
 +
<div class="spoiler" id="spoiler2">
 +
<div class="textImage">
 +
<div class="left2"><span class="tekst1">
 +
//text goes here
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
 +
 +
</div>
 +
</span>
 +
<div class="left2imglink">
 +
<img class="linkImg" src="https://static.igem.org/mediawiki/2015/6/68/TU_Eindhoven_RIVM_Meeting.png">
 +
<div class="linkTxt">
 +
<span class="caption">
 +
//caption goes here
 +
</span>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
</li>
  
 
</html>
 
</html>

Revision as of 07:00, 15 September 2015





Stakeholders


To obtain more insight in the feasibility of our idea, we talked to many experts within different fields. Among the people we approached are doctors, researchers, students, but also people working in non-academic fields such as at ministeries and professional advisors. Each of them was invited to give their perspectives on our work. We also wondered if they could see the benefits of our device within our application scenarios and if they had any other suggestions for usage. Moreover, we gave them space to criticize our idea, and thereby advise us about aspects of our design that could be perfected. With their involvement, we could further develop our ideas. A short overview of each talk is given below.

General

  • RIVM & Rathenau
    RIVM is the national institute involved in regulation of safety and environment. The Rathenau Institute is involved in the consideration of technological advancements and their role in society. Both institutes regularly experience the clash that occurs when technological novelties are presented to a poorly informed public. To promote dialogue between society and technological researches the RIVM and Rathenau Institute together organized a symposium about synthetic biology and its role in society.
    The iGEM-teams of the Netherlands had an active role in the organization of the symposium and were given an opportunity to present their projects to a diverse audience (consisting of amongst others employees of the RIVM and Rathenau and ministries). The presentation was followed by a discussion about societal problems that play a role when considering synthetic biology. Read more on this event here:
    We presented our project to policymakers attending the SynBio convention and held a discussion afterwards.
  • Bureau GGO
    //text goes here
    //image caption goes here
  • Virgil Rerimassie
    //text goes here
    //caption goes here
  • RIVM Regelgeving
    //text goes here
    //caption goes here


Intellectual Property Rights


A possible obstacle for our design is the fact that we make use of aptamers as one of the main components; many of the discovered aptamers are currently still patented. Therefore, it was interesting to explore if this could pose any further problems in the future. Therefore, we contacted some experts on the area of patent law. An overview is given below:
  • Ir. P.H. (Peter) van Dongen - RVO/Agentschap NL - Patent advisor for universities and technological institutes
    Ir. Van Dongen is very experienced when it comes to patent law. He explained to us some of the basic principles behind it and some factors we should pay attention to.
    Patents are granted to any scientist who applied for it and who came up with a novel invention that was never earlier described anywhere in the world, that is not obvious and that could be exploited economically. Hereby it is important to consider that patents are granted per country and it might not be economically favourable for some companies to apply for a patent in small countries like the Netherlands. Patent keepers need to pay tax for the patent they hold in each country, so sometimes it is not beneficious to have a patent-right in each country.
    Once a company/institute has patent on a specific invention, it has rights to exploit this product economically for 20 years. People can buy the patent or ask for a license, in which case part of the profit is directly transferred to the company who owns the patent.
    Ir. Van Dongen doesn’t foresee much problems in our research. He could tell us that there is an exception to the patent law when it comes to the use of a product for scientific research. Only if we were to introduce our device to the market we would encounter patent regulation.
    //caption goes here
  • Ir. Annika van Rosmalen - Responsible at HollandBio for communication about bio-based technologies
    We talked to Ir. Van Rosmalen about the potential of our device. Since Ir. Van Rosmalen works at HollandBio, a Dutch association for companies involved in the production of bio-based technologies, we figured she would have some insights into regulation involved in bio-based technologies like ours.
    Ir. Van Rosmalen was quite enthusiastic about the idea of an quick and easy detection-device. She advised us to further emphasize the advantages of using bacteria in order to avoid a lot of ethical complaints.
    About patent-regulation she could tell us that the 20 years of patent rights usually only give the patent-holder only 15 years to earn back his/her expenses. This is because an application for patents on different aspects of the design is made at the beginning of the research. However usually it takes at least 5 more years for the research to be published.
    One other important aspect is that the patent-holders themselves are responsible to keep check of any illegal use of their product. This is not supported by any other agency. Therefore it takes quite some work to keep your patented product safe.
  • Patentpunt
    //text goes here
    //caption goes here
//caption goes here